Program Swiss RNA Therapeutics Summit 2023

TimeSession
08:30Welcome Coffee
09:15Opening Remarks
09:20Welcome Address: Christian Leumann – Rector of the University of Bern
09:30Keynote I: Mustafa Diken – Vice President of Vaccines & Immunology, BioNTech – “mRNA based vaccines and beyond” (Chair: Jonathan Hall)
10:10Company Presentations I:
Mario Jauker – Bachem
Torsten Schmidt – Lonza
Soham Mandal – Axolabs
Nicolas Chornet – Moderna
11:10Coffee Break
Sponsored by:
11:40Panel I – RNA Therapeutics in Switzerland: How to Join Forces:
Mustafa Diken – BioNTech
Oliver Mühlemann – University of Bern & Director NCCR RNA & Disease
Nicole Schaad – State Secretariat for Education, Research and Innovation
Volker Thiel – EDI & University of Bern, Swiss National COVID-19 Science Task Force
Moderated by Dominik Theler
12:25Company Talent Presentations:
Daniel Wanner – Bachem
Cédric Vonarburg – CSL Behring
Dmitry Kopelyanskiy – Haya
Theo Rowley – Moderna
Erich Koller – Roche
Stefan Reber – Skyhawk
Versameb – Klaas Zuideveld
13:00Lunch & Meet the Talent Session
Lunch sponsored by:
14:15Keynote II: Shalini Andersson – Vice President Oligonucleotide Discovery, AstraZeneca – “Developing Next Generation Oligonucleotide therapeutics” (Chair: Jonathan Hall)
14:55Panel II: Investors
Bettina Ernst – Bernina BioInvest
Gabriela Ecco – +ND Capital
Klaas Zuideveld – Versameb
Moderated by Carsten Laue
15:30Coffee Break
Sponsored by:
16:00

Company Presentations II:
Tom Edwardson – Procavea
Riccardo Dainese – Alithea Genomics
Stefanie Urlinger – Cimeio
Daniel Blessing – Haya
Friedrich Metzger – Versameb
16:50Swiss Regulatory Aspects – Julia Djonova – Swissmedic
17:05Panel III – Technological Trends & Needs
Shalini Andersson – VP Oligonucleotide Discovery, AstraZeneca
Julia Djonova – Swissmedic
Lukas Jeker – University of Basel & co-founder Cimeio
Markus Stoffel – ETH Zurich & SAB Alnylam
Moderated by Jonathan Hall
17:50Concluding Remarks
18:00Apéro
sponsored by the Bern Economic Development Agency